1

Sangam Health Care Products

531625 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

2
  • The company has delivered a poor sales growth of 3.32% over past five years.
  • Debtor days have increased from 76.2 to 114 days.

Growth Rate

Revenue Growth
-4% lower than 3Y
Net Income Growth
-2% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
2.56
3.05
3.53
2.97
3.39
3.62
2.87
2.58
2.82
3.04
2.72
2.66
3.03
Expenses
2.94
2.54
2.66
2.79
3
3.24
2.46
2.29
2.7
2.74
2.42
3.14
2.59
Operating Profit
-0.38
0.51
0.87
0.18
0.39
0.38
0.41
0.29
0.12
0.3
0.3
-0.48
0.44
OPM %
-14.84%
16.72%
24.65%
6.06%
11.5%
10.5%
14.29%
11.24%
4.26%
9.87%
11.03%
-18.05%
14.52%
Other Income
0
0
0
0
0
0
0
0.02
0
0
0
0.02
0
Interest
0.01
0
0.01
0.01
0
0
0
0.01
0
0
0
0
0
Depreciation
0.3
0.3
0.3
0.31
0.3
0.3
0.3
0.31
0.01
0.01
0.01
0.02
0.01
PBT
-0.69
0.21
0.56
-0.14
0.09
0.08
0.11
-0.01
0.11
0.29
0.29
-0.48
0.43
Tax %
0%
0%
0%
0%
0%
0%
0%
-1900%
9.09%
17.24%
34.48%
-39.58%
27.91%
Net Profit
-0.69
0.2
0.56
-0.14
0.08
0.07
0.11
0.19
0.1
0.23
0.2
-0.28
0.31
EPS in Rs
-0.46
0.13
0.38
-0.09
0.05
0.05
0.07
0.13
0.07
0.15
0.13
-0.19
0.21
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
25.44
23.71
24.16
20.99
21.04
21.81
9.54
8.7
10.76
12.11
12.46
11.23
11.45
Expenses
21.43
20.19
24.55
25.62
20.09
19.78
10.86
9.1
10.88
10.67
11
10.98
10.89
Operating Profit
4.01
3.52
-0.39
-4.63
0.95
2.03
-1.32
-0.4
-0.12
1.44
1.46
0.25
0.56
OPM %
15.76%
14.85%
-1.61%
-22.06%
4.52%
9.31%
-13.84%
-4.6%
-1.12%
11.89%
11.72%
2.23%
4.89%
Other Income
4.75
0.27
0.12
18.41
0.47
2.93
0.02
0
0
0
0.02
0.02
0.02
Interest
5.46
3.8
5.05
3.33
2.1
0.29
0.07
0.11
0.03
0.02
0.01
0.01
0
Depreciation
1.51
1.53
1.52
1.52
1.5
1.26
1.22
1.22
1.22
1.22
1.22
0.06
0.05
PBT
1.79
-1.54
-6.84
8.93
-2.18
3.41
-2.59
-1.73
-1.37
0.2
0.25
0.2
0.53
Tax %
0%
0%
0.29%
17.36%
-6.88%
-18.77%
-11.2%
-10.4%
-14.6%
-110%
-76%
75%
—
Net Profit
1.79
-1.54
-6.86
7.37
-2.03
4.05
-2.3
-1.55
-1.16
0.42
0.45
0.05
0.46
EPS in Rs
1.2
-1.04
-4.62
4.96
-1.37
2.73
-1.55
-1.04
-0.78
0.28
0.3
0.03
0.3
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
Reserves
-31.81
-33.35
-37.85
-28.59
-34.83
-30.78
-33.08
-34.63
-35.79
-35.37
-34.92
-34.71
Borrowings
35.37
36.08
37.27
17.25
21.15
17.59
18.21
23.4
21.08
19.34
21.98
21.93
Other Liabilities
14.15
15.13
13.65
18.66
22.59
11.29
9.43
5.46
7.92
7.67
9.42
9.14
Total Liabilities
32.57
32.72
27.93
22.18
23.77
12.96
9.42
9.09
8.07
6.5
11.34
11.22
Fixed Assets
23.94
22.63
21.44
19.93
18.65
6.24
5.02
3.81
2.61
1.39
0.18
0.3
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
8.63
10.09
6.49
2.25
5.12
6.72
4.4
5.28
5.46
5.11
11.16
10.92
Total Assets
32.57
32.72
27.93
22.18
23.77
12.96
9.42
9.09
8.07
6.5
11.34
11.22
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-16.8
-0.37
-4.44
-5.97
11.05
-11.08
0.14
0.99
2.49
1.94
1.49
0.03
Investing
4.71
-0.21
-0.29
18.7
-1.02
11.18
0.02
0.02
0
0
0
-0.02
Financing
12.22
2.07
3.13
-12.72
-10.15
-0.02
-0.13
-0.13
-2.35
-1.77
0
-0.06
Net Cash Flow
0.13
1.48
-1.6
0.01
-0.12
0.07
0.03
0.88
0.14
0.18
1.49
-0.06
Free Cash Flow
-16.84
-0.58
-4.78
-5.98
10.82
0.08
0.14
0.99
2.49
1.94
1.49
0.03
CFO/OP
-419
-11
1,138
129
1,171
-546
-11
-248
-2,075
135
102
12
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
3.73
2
0.91
0.17
6.07
8.37
26.4
25.59
21.37
8.14
106
114
Inventory Days
327
257
136
21.81
107
137
68.48
133
162
101
72.01
62.27
Days Payable
259
286
156
127
155
219
285
191
384
359
362
379
Cash Conversion Cycle
71.32
-26.94
-19.07
-106
-41.64
-73.53
-190
-32.73
-201
-250
-184
-203
Working Capital Days
-225
-240
-254
-339
-628
-346
-880
-981
-107
-110
-77.92
-75.41
ROCE %
37.12%
12.55%
-11.23%
137.75%
-3.4%
259.65%
-303.61%
-89.5%
-70.9%
—
69.33%
10.5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sangam Health Care Products insights

29 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

Promot.70.12%DIIs8.43%Public21.44%As ofJun 2026

Documents

Frequently Asked Questions about Sangam Health Care Products

What does Sangam Health Care Products Ltd do?
Sangam Health Care Products is engaged manufacturing and trading of medical products
Where is Sangam Health Care Products Ltd (1269907) listed?
Sangam Health Care Products Ltd trades under code 531625 on the BSE.
Which sector does Sangam Health Care Products Ltd belong to?
Sangam Health Care Products Ltd is classified under the Healthcare sector, in the Healthcare Equipment & Supplies industry.

Company Information

Sangam Health Care Products is engaged manufacturing and trading of medical products

Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/1269907.md for Sangam Health Care Products Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List